These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30257868)

  • 41. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
    Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA
    J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans.
    Adage T; Piccinini AM; Falsone A; Trinker M; Robinson J; Gesslbauer B; Kungl AJ
    Br J Pharmacol; 2012 Nov; 167(6):1195-205. PubMed ID: 22747966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine.
    Salanga CL; Dyer DP; Kiselar JG; Gupta S; Chance MR; Handel TM
    J Biol Chem; 2014 May; 289(21):14896-912. PubMed ID: 24727473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.
    Lau EK; Paavola CD; Johnson Z; Gaudry JP; Geretti E; Borlat F; Kungl AJ; Proudfoot AE; Handel TM
    J Biol Chem; 2004 May; 279(21):22294-305. PubMed ID: 15033992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secreted poxvirus chemokine binding proteins.
    Lalani AS; McFadden G
    J Leukoc Biol; 1997 Nov; 62(5):570-6. PubMed ID: 9365110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.
    Laurence JS; Blanpain C; De Leener A; Parmentier M; LiWang PJ
    Biochemistry; 2001 Apr; 40(16):4990-9. PubMed ID: 11305915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors.
    Smith CA; Smith TD; Smolak PJ; Friend D; Hagen H; Gerhart M; Park L; Pickup DJ; Torrance D; Mohler K; Schooley K; Goodwin RG
    Virology; 1997 Sep; 236(2):316-27. PubMed ID: 9325239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral chemokine-binding proteins.
    Seet BT; McFadden G
    J Leukoc Biol; 2002 Jul; 72(1):24-34. PubMed ID: 12101259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NMR Methods for Characterization of Glycosaminoglycan-Chemokine Interactions.
    Pomin VH; Rajarathnam K
    Methods Mol Biol; 2023; 2597():143-157. PubMed ID: 36374420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
    Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
    Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A guide to chemokines and their receptors.
    Hughes CE; Nibbs RJB
    FEBS J; 2018 Aug; 285(16):2944-2971. PubMed ID: 29637711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methods for the Recognition of GAG-Bound Chemokines.
    Bonvin P; Gueneau F; Fischer N; Proudfoot A
    Methods Enzymol; 2016; 570():73-85. PubMed ID: 26921942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.
    Giblin SP; Ranawana S; Hassibi S; Birchenough HL; Mincham KT; Snelgrove RJ; Tsuchiya T; Kanegasaki S; Dyer D; Pease JE
    Front Immunol; 2023; 14():1254697. PubMed ID: 37942327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New insights into the structure and function of chemokine receptor:chemokine complexes from an experimental perspective.
    Gustavsson M
    J Leukoc Biol; 2020 Jun; 107(6):1115-1122. PubMed ID: 31965639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NMR and molecular modeling reveal specificity of the interactions between CXCL14 and glycosaminoglycans.
    Penk A; Baumann L; Huster D; Samsonov SA
    Glycobiology; 2019 Sep; 29(10):715-725. PubMed ID: 31264681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate.
    Sepuru KM; Rajarathnam K
    J Biol Chem; 2019 Oct; 294(43):15650-15661. PubMed ID: 31455633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice.
    Vanheule V; Crijns H; Poosti F; Ruytinx P; Berghmans N; Gerlza T; Ronsse I; Pörtner N; Matthys P; Kungl AJ; Opdenakker G; Struyf S; Proost P
    Clin Exp Allergy; 2018 Oct; 48(10):1333-1344. PubMed ID: 29978510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycosaminoglycans mediate cell surface oligomerization of chemokines.
    Hoogewerf AJ; Kuschert GS; Proudfoot AE; Borlat F; Clark-Lewis I; Power CA; Wells TN
    Biochemistry; 1997 Nov; 36(44):13570-8. PubMed ID: 9354625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System.
    Proudfoot AEI; Johnson Z; Bonvin P; Handel TM
    Pharmaceuticals (Basel); 2017 Aug; 10(3):. PubMed ID: 28792472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.